{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:36:24Z","timestamp":1794065784837,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.burns.2026.108138","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:06:27Z","timestamp":1782774387000},"page":"108138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of augmented renal clearance on piperacillin and meropenem exposure in critically ill adult burn patients: A prospective observational study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1396-4066","authenticated-orcid":false,"given":"L\u0151rinc","family":"Z\u00e1vorszky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint Gergely","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Holub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Tarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Galg\u00f3czi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Er\u0151ss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8068-9017","authenticated-orcid":false,"given":"\u00c1d\u00e1m","family":"P\u00e9ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nika","family":"K\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsoltn\u00e9","family":"Bir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-5633","authenticated-orcid":false,"given":"Gell\u00e9rt","family":"Karvaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botond","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.burns.2026.108138_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.burns.2026.108138_bib2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"issue":"15","key":"10.1016\/j.burns.2026.108138_bib3","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"issue":"48","key":"10.1016\/j.burns.2026.108138_bib4","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1556\/650.2023.32896","article-title":"[Therapeutic drug monitoring of beta-lactam antibiotics in critically ill adult patients]","volume":"164","author":"Z\u00e1vorszky","year":"2023","journal-title":"Orv Hetil"},{"issue":"3","key":"10.1016\/j.burns.2026.108138_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","article-title":"Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial","volume":"48","author":"Hagel","year":"2022","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.burns.2026.108138_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s13054-020-03272-z","article-title":"Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)","volume":"24","author":"Abdulla","year":"2020","journal-title":"Crit Care Lond Engl"},{"issue":"8","key":"10.1016\/j.burns.2026.108138_bib7","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically Ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.burns.2026.108138_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcrc.2021.12.013","article-title":"Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population - A prospective, multi-center, observational study (BLAST 1)","volume":"68","author":"Chua NG","year":"2022","journal-title":"J Crit Care"},{"issue":"6","key":"10.1016\/j.burns.2026.108138_bib9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.burns.2026.108138_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/phar.2842","volume":"43","author":"Hong","year":"2023","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"11","key":"10.1016\/j.burns.2026.108138_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.burns.2026.108138_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pharmaceutics9030036","article-title":"Augmented renal clearance in critical illness: an important consideration in drug dosing","volume":"9","author":"Mahmoud","year":"2017","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.burns.2026.108138_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00134-014-3641-9","article-title":"Comparison of different equations to assess glomerular filtration in critically ill patients","volume":"41","author":"Carlier","year":"2015","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.burns.2026.108138_bib14","first-page":"433","volume":"27","author":"Kanna","year":"2023","journal-title":"Indian J Crit Care Med Peer-Rev Publ Indian Soc Crit Care Med"},{"issue":"10","key":"10.1016\/j.burns.2026.108138_bib15","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/jcpt.13695","article-title":"Validation of the augmented renal clearance in trauma intensive care scoring system for augmented renal clearance prediction in a trauma subgroup of a mixed ICU population","volume":"47","author":"Jabamikos","year":"2022","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.burns.2026.108138_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/TA.0000000000001387","article-title":"Identifying augmented renal clearance in trauma patients: validation of the augmented renal clearance in trauma intensive care scoring system","volume":"82","author":"Barletta","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.burns.2026.108138_bib17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jss.2024.05.026","article-title":"Validation of two scoring tools to predict risk of augmented renal clearance in trauma patients","volume":"300","author":"Farrar","year":"2024","journal-title":"J Surg Res"},{"issue":"5","key":"10.1016\/j.burns.2026.108138_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/antibiotics10050557","article-title":"Pharmacokinetic\/pharmacodynamic target attainment based on measured versus predicted unbound ceftriaxone concentrations in critically ill patients with pneumonia: an observational cohort study","volume":"10","author":"Gijsen","year":"2021","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.burns.2026.108138_bib19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/CCM.0000000000000029","article-title":"Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*","volume":"42","author":"Udy","year":"2014","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.burns.2026.108138_bib20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/jbcr\/irad107","article-title":"Augmented renal function in burn patients: occurrence and discordance with commonly used methods to assess renal function","volume":"44","author":"Mueller","year":"2023","journal-title":"J Burn Care Res"},{"issue":"3","key":"10.1016\/j.burns.2026.108138_bib21","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1097\/TA.0000000000000191","article-title":"Modified augmented renal clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients","volume":"77","author":"Akers","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"10.1016\/j.burns.2026.108138_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijantimicag.2014.12.017","article-title":"Augmented renal clearance, low \u03b2-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study","volume":"45","author":"Huttner","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.burns.2026.108138_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13054-015-0750-y","article-title":"Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?","volume":"19","author":"Udy","year":"2015","journal-title":"Crit Care"},{"issue":"_1","key":"10.1016\/j.burns.2026.108138_bib24","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/jbcr\/iry006.084","article-title":"Augmented creatinine clearance in severely injured burn patients","volume":"39","author":"Eidelson","year":"2018","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2026.108138_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jbcr\/irae036.145","article-title":"Antibiotic serum concentrations in burn patients with augmented renal clearance and adjusted regimens","volume":"45","author":"Mueller","year":"2024","journal-title":"J Burn Care Res Publ Am Burn Assoc"},{"key":"10.1016\/j.burns.2026.108138_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.20516","article-title":"Development and validation of the sequential organ failure assessment (SOFA)-2 score","author":"Ranzani","year":"2025","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.burns.2026.108138_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.burns.2026.108138_bib28","unstructured":"Giske C.G., Martinez L. et al. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance [Internet]. 2017 [cited 2026 May 13]. Available from: \u3008https:\/\/www.eucast.org\/\u3009."},{"issue":"2","key":"10.1016\/j.burns.2026.108138_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00210-018-1573-6","article-title":"After standard dosage of piperacillin plasma concentrations of drug are subtherapeutic in burn patients","volume":"392","author":"Olbrisch","year":"2019","journal-title":"Naunyn Schmiede Arch Pharmacol"},{"issue":"12","key":"10.1016\/j.burns.2026.108138_bib30","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1128\/AAC.00951-13","article-title":"Protein Binding of \u03b2-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?","volume":"57","author":"Wong","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.burns.2026.108138_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijantimicag.2016.06.013","article-title":"Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients","volume":"48","author":"Zander","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.burns.2026.108138_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bcp.12817","article-title":"Creatinine-based equations for the adjustment of drug dosage in an obese population","volume":"81","author":"Bouquegneau","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.burns.2026.108138_bib33","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"9","key":"10.1016\/j.burns.2026.108138_bib34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.burns.2026.108138_bib35","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group","volume":"2","author":"Khwaja","year":"2012","journal-title":"KDIGO Clin Pract Guidel Acute Kidney Inj"},{"issue":"1","key":"10.1016\/j.burns.2026.108138_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.burns.2026.108138_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13054-024-04911-5","article-title":"Impact of attaining aggressive vs. conservative PK\/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis","volume":"28","author":"Gatti","year":"2024","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.burns.2026.108138_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.burns.2026.108138_bib39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.burns.2024.03.006","article-title":"Subtherapeutic beta-lactam plasma concentrations in critically ill burned patients in the era of continuous intravenous administration","volume":"50","author":"Duputi\u00e9","year":"2024","journal-title":"Burns"},{"issue":"7","key":"10.1016\/j.burns.2026.108138_bib40","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.02089-13","article-title":"Population pharmacokinetic analysis of piperacillin in burn patients","volume":"58","author":"Jeon","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.burns.2026.108138_bib41","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/bcp.15138","article-title":"Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno-venous haemofiltration","volume":"88","author":"Selig","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.burns.2026.108138_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.11-1671","article-title":"Subtherapeutic Initial \u03b2-lactam concentrations in select critically Ill patients","volume":"142","author":"Udy","year":"2012","journal-title":"CHEST"},{"issue":"1","key":"10.1016\/j.burns.2026.108138_bib43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-025-05445-0","article-title":"First dose target attainment with extended infusion regimens of piperacillin and meropenem","volume":"29","author":"Beijer","year":"2025","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.burns.2026.108138_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijantimicag.2016.12.022","article-title":"Association between augmented renal clearance and clinical outcomes in patients receiving \u03b2-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial","volume":"49","author":"Udy","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.burns.2026.108138_bib45","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1038\/s41598-024-58200-w","article-title":"Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: a systematic review and meta-analysis of randomized clinical trials and observational studies","volume":"14","author":"Guly\u00e1s","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.burns.2026.108138_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00005373-200208000-00013","article-title":"Accuracy of short-duration creatinine clearance determinations in predicting 24-hour creatinine clearance in critically ill and injured patients","volume":"53","author":"Cherry","year":"2002","journal-title":"J Trauma"},{"issue":"1","key":"10.1016\/j.burns.2026.108138_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/10600280241241820","article-title":"Abbreviated urine collection compared with 24-hour urine collection for measuring creatinine clearance in adult critically Ill patients: a systematic review","volume":"59","author":"Saad","year":"2025","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.burns.2026.108138_bib48","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00134-007-0745-5","article-title":"Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a single-center study","volume":"33","author":"Herrera-Guti\u00e9rrez","year":"2007","journal-title":"Intensive Care Med"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417926002901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417926002901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:13:05Z","timestamp":1790367185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417926002901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0305417926002901"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2026.108138","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of augmented renal clearance on piperacillin and meropenem exposure in critically ill adult burn patients: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2026.108138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108138"}}